METOJECT SUBCUTANEOUS
MEDEXUS PHARMACEUTICALS INC.
Quick answers
Is there a shortage of METOJECT SUBCUTANEOUS in Canada?
No. There is no current shortage of METOJECT SUBCUTANEOUS 20MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
METHOTREXATE SODIUM INJ 20MG
LEDERLE CYANAMID CANADA INC.
METHOTREXATE-PWS IM IV IAR INT IVR 20MG/VIAL
WYETH-AYERST CANADA INC.
METHOTREXATE INJECTION USP
PFIZER CANADA ULC
METHOTREXATE SODIUM INJECTION USP
PFIZER CANADA ULC
METHOTREXATE INJECTION, BP
PHARMASCIENCE INC
METOJECT
MEDEXUS PHARMACEUTICALS INC.
DIN
02454866
Strength
20MG
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
METHOTREXATE (METHOTREXATE SODIUM)
See all METHOTREXATE (METHOTREXATE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MEDEXUS PHARMACEUTICALS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
1MG · DIN 02469332
1.5G · DIN 02504928
7.5MG · DIN 02320029
12.5MG · DIN 02454750
10MG · DIN 02454831
15MG · DIN 02454858
22.5MG · DIN 02454777
17.5MG · DIN 02454769
25MG · DIN 02454874
DIN 02459655
25MG · DIN 02162431
100% · DIN 02346672